Responsiveness to anti-PD-1 and anti-CTLA-4 immune checkpoint blockade in SB28 and GL261 mouse glioma models

Cited by papers we hold 5

• Immunotherapy for glioblastoma: the promise of combination strategies · 2022
  No notice
• Targeting Treg cells with GITR activation alleviates resistance to immunotherapy in murine glioblastomas · 2021
  No notice
• Mouse models of glioblastoma for the evaluation of novel therapeutic strategies · 2021
  No notice
• Heterogeneity of response to immune checkpoint blockade in hypermutated experimental gliomas · 2020
  No notice
• Immune phenotyping of diverse syngeneic murine brain tumors identifies immunologically distinct types · 2020
  Corrected

Reads

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.